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SERUM AND URINARY LYSOZYME IN PATIENTS WITH MASTO-
CYTOSIS (URTICARIA PIGMENTOSA), SYSTEMIC SCLERO-
DERMA AND PSORIASIS*
SOICHIRO SASAKI, M.D. AND GUSTAV ASBOE-HANSEN, M.D.
In 1922 Sir Alexander Fleming (1) reported
the presence of a bacteriolytic principle in
tears, egg White and other animal fluids
Which he called lysozyme.
The lytic action on susceptible organisms
Was found to be due to the hydrolysis of a
mucoid component of the cell wall. This com-
ponent Was identified as a high polymer mu-
copolysaccharide Which was hydrolyscd at a
rate comparable to the speed of bacterial ly-
sis (2).
It seems that little clinical investigation of
lysozyme has been made, though it has been
studied thoroughly bacteriologically (3) and
biochemically (4, 5, 6). Taniguchi and Sasaki
(7) were the first to report on serum lysozyme
activity in skin diseases.
In the present study an attempt was made
to measure serum and urinary lysozyme ac-
tivities in normal individuals and patieuts
with mastocytosis (urticaria pigmentosa), sys-
temic seleroderma aud psoriasis vulgaris.
MATERIALS AND METHODS
The blood and urine specimens were obtained
from 43 normal individuals, 11 patients with
urticaria pigmentosa, 16 with systemic sclerederma
and 34 with psoriasis vulgaris. The supernatants
of blood and urine centrifuged at 2,500 g for five
minutes were used for the assay.
The enzymic activities were assayed by the
modified method of Litwack (8) and Fogelson ci
al (9) as follows: 2.0 ml of buffer solution, 0.4 ml
of the sample, and 1.6 ml of the substrate were
incubated at 37° C for five minutes. The buffer
was M/15 Sorensen phosphate buffer pH 6.2
containing 0.071 N NaCl (10). The substrate
solution was prepared by suspending 10 mg ly-
ophilized Microceccus lysodeiktieus1 in 100 ml of
the buffer solution. The absorption was measured
at 645 ma on a Beckman DB spectrophotometer.
The values observed were corrected for non-
specific absorption by subtracting the optical den-
sity of a color blank containing 0.4 ml of the
Received for publication March 21, 1967.
* From the University of Copenhagen, Depart-
ment of Dermatology, Rigsbospital, Copenhagen,
Denmark.
1 Micrococcus lysodeikticus was generously sup-
plied by Eisai Co. Ltd., Tokyo, Japan.
sample and 3.6 ml of the buffer solution. Standard
curves were produced with egg white lysozyme
(Sigma Chemical Co., Mo., U.S.A.).
RESULTS
The serum lysozyme activity in 23 normal
males was found to be 6.5 0.2 pg/ml, and
6.4 0.2 fig/ml in 20 normal females (Table
1). There was no significant difference be-
tween them.
Serum and urinary lysozyme activities of
the patients with urticaria pigmentosa, sys-
temic soleroderma and psoriasis vulgaris are
listed in Tables 2, 3 and 4. Serum lysozyme
values were 4.5 0.3 fig/ml in urticaria pig-
mentosa, 5.4 0.3 fig/mI in systemic sclero-
derma, and 6.4 1.2 g/ml in psoriasis
vulgaris. The mean values of urinary lysozyme
were 0.3 ag/mI in urticaria pigmentesa, 0.4
pg/ml in systemic scleroderma and 0.8 fig/ml
in psoriasis vulgaris.
Figure 1 illustrates the distribution of
serum lysozyme values of normal individuals
and of patients with the three different skin
diseases.
DISCUSSION
Lysezyme is an enzyme which is widely
distributed in plants and animals, especially
in the latter. It exists in body fluids e.g. tears,
saliva, nasal secretion, gastric juice, milk,
blood plasma and leukocytes (1, 11). The en-
zyme is a basic protein of low molecular
weight (around 15,000). Its lytie activity
against certain gram-negative and gram-
positive bacteria is suggestive of a role of the
lysozyme in the defence against bacterial in-
vasion (3). A possible source of urinary lyso-
zyme are peritubular macrophages. However,
the possibility exists that urinary lysozyme
represents an overflow from the plasma or evi-
dence of glomerular damage. Lysozyme is
known as a mucopolysaceharidase which acts
on /1(1 -+ 4) N-acetylglucosaminides (12).
The fact that mast cells synthesize acid
mucopolysaccharides, and that scleroderma is
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TABLE 1
Serum lysozyme values in normal subjects
TABLE 2
Serum and urinary lysozyme values in mastocytosis
(urticaria pigmenlosa)
No.
1
2
3
4
5
6
7
8
9
10
11
Name
A. L.
w. S.
T. E.
S. H.
M. S.
H. M.
P. A.
A. F.
G. J.
I. H.
B. H.
Age
16
22
6
34
4
1
21
6
6
20
22
Sex
F
M
M
M
M
M
M
F
F
F
F
Serum
lysozyme
values
(5g/ml)
4.1
2.8
2.7
5.2
5.2
4.9
5.1
4.1
4.5
5.3
5.2
Males Females
Lyso- Lyso-
No. Name Age
(5g/ml)
No. Name Age
(5g/ml)
1 B. A. 22 5.8 1 R. B. 30 5.8
2 F. J. 33 7.4 2 G. R. 47 7.5
3 Y. F. 23 5.8 3 G. A. 16 5.8
4 S. S. 26 5.4 4 A. L. 18 6.0
5 E. R. 27 6.9 5 Y. L. 25 5.5
6 L. B. 46 6.9 6 B. N. 20 6.3
7 B. T. 27 8.5 7 G. Q. 34 5.8
8 Y. T. 24 5.3 8 C. V. 20 5.7
9 J. 0. 23 7.0 9 H. P. 19 6.5
10 A. R. 25 5.9 10 B. S. 18 8.0
11 J. II. 21 6.5 11 E. S. 19 7.7
12 T. H. 22 6.3 12 M. A. 18 7.5
13 E. J. 25 8.0 13 A. V. 19 8.0
14 F. V. 34 8.0 14 P. C. 5.7
15 K. L. 19 7.8 15 M. J. 20 5.1
16 V. V. 24 6.2 16 R. I. 18 7.4
17 Y. A. 29 6.8 17 A. L. 18 5.7
18 P. L. 20 5.8 18 L. W. 23 5.2
19 C. C. 21 5.4 19 B. F. 20 6.1
20 A. R. 21 6.9 20 M. B. 22 7.6
21 F. S. 22 7.8
22 A. C. 25 5.0
23 H.O.22 5.0
Results 6.5 0.2* 6.4 0.2*
Range of 5.0—8.5 5.1—8.0
values
Urinary
lysozyme
values(g/ml)
0
0
0
1.3
0
0
0
0
0
1.0
1.2
0.3
0—1.3
Results
Range of values
4.5 0.3*
2.7—5.3
* Results are expressed as the mean the
standard error of the mean.
TABLE 3
Serum and urinary lysozyme values
in systemic scleroderma
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Name
SE.
B.R.
E.A.
D.M.
I.L.
I.J.
L.S.
B.L.
K.B.
K.J.
K. K.
S. L.
K.K.
K. K.
M.J.
B. H.
Age
57
55
51
47
35
26
42
47
64
57
66
42
51
55
11
17
Sex
M
F
F
F
F
M
M
F
F
F
F
M
F
F
M
F
Serum
lysozyrne
(g/ml)
5.3
5.5
5.0
4.0
4.3
3.8
3.8
5.6
5.5
6.6
6.4
5.5
7.5
8.1
3.5
6.5
Urinary
lysozyme
(g/ml)
0
0
0
0
0
0
0
0.6
0
0
0.5
0.8
1.3
0.9
0
1.5
0.4
0—1.5
Results
Range of values
5.4 0.3*
3.5—8.1
* Results are expressed as the mean the
standard error of the mean.
a mesenchymosis, the development of which
may depend on changes in mucopolysaceharide
metabolism (13) led to the studies of lysozyme
in mastocytosis and scleroderma. In contradis-
tinction, the connective-tissue involvement in
psoriasis is relatively scarce. The mastocytosis
cases were of the macular type showing urtica-
tion as a response to mechanical trauma. The
cases of scleroderma were of the acrosclerosis
type. The severity and extensiveness of the
sclerodermie changes were very similar from
case to case. The psoriasis lesions were num-
mular.
The average normal value for serum lysozyme
activity obtained in the present study is in
* Results are expressed as the mean the
standard error of the mean.
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TABLE 4
Serum and urinary lysozyme values
in psoriasis vulgaris
iiificantly lowered serum lysozyme values (P <
0.001). The scieroderma patients showed corn-
paratively low serum values, the difference from
normal being statistically significant (P < 0.01).
On the other hand, the serum lysozyme level
in psoriatic patients did not differ signifi-
.le
(sg/ml)
cantly from the level of normal individuals
0 (P > 0.05), and the range varied widely. On
1.0 the basis of the obtained results, no eonclu-
1.2 sions about any relationship between serum
1.8
0.8
09
0:9
0.9
lysozyme activity and the pathology of psoria-
sis vulgaris can be drawn. It was also ap-
parent that no correlation between the exten-
siveriess of the diseases and the lysozyme
values could be demonstrated.
From the data of lysozyme assays of urine
0 samples, it is evident that the urines
3.8 contained little lysozyme. Fleming (1), Proc-
3.5 kop and Davidson (14), Wilson and Hadley
1.0 (18) and Burghartz and Boosfeld (19) re-
0.5
0
0
0
0
ported that urinary lysozyme activity in nor-
mal subjects was nil or very low. The low
lysozyme content of the urine renders the
assay somewhat unreliable. The values oh-
tamed for urinary lysozyme in urticaria pig-
mentosa, systemic scleroderma and psoriasis
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
Name
J. M.
B. H.
C. P.
M.W.
S. G.
B. H.
F. S.
J. A.
H. J.
J. S.
G. G.
F. P.
T. L.
1K.
E. J.
M. N.
E. T.
L. B.
J. F.
C. D.
L. B.
P. B.
K. H.
0. T.
D. J.
N. L.
K. E.
A. V.
J. P.
E. M.
E. M.
I. H.
E. B.
A. H.
Age
37
31
28
12
28
58
18
72
69
17
44
76
24
41
45
56
52
44
64
57
7
7
51
20
83
62
54
21
53
36
48
28
19
15
Sex
M
F
F
F
M
F
F
M
M
M
F
M
M
F
F
M
F
M
F
M
F
F
F
M
F
M
M
F
M
F
F
F
F
F
Serum
lysozyme
values(g/ml)
4.3
3.4
5.9
5.8
5.1
5.3
5.6
5.6
3.0
7.0
3.4
10.3
9.4
8.4
7.5
4.3
5.1
5.4
5.6
8.2
5.2
6.8
7.5
7.6
7.5
6.8
7.6
7.3
10.0
7.5
6.7
4.5
6.9
7.2
10
0.8
0.3
0.9
0
0.9
0.6
0.8
0
0.8
0.5
0
2.1
rU
.i:.
t.
I.
E
>
E
N0
U,
of values
6.4 1.2*
3.0-40.3
0.8 0.2*
0—3.8
+ .
* Results are expressed as the mean the
standard error of the mean.
agreement with that published by Prockop and
Davidson (14) i.e. 6.4 g/ml.
Changes of the mueopolysaccharide con-
tent in serum and urine of the patients suf-
fering from mastocytosis (urticaria pigmen-
tosa) have been demonstrated by Asboe-Hansen
and Clausen (15, 16, 17). The iirticaria pig-
mentosa patients of this study showed sig-
5
Normal Mastocytosis Systemic Psoriasis
Scleroderma Vutgaris
Fia. 1. Distribution of serum lysozyme values
in normal subjects and patients with masto-
cytosis (urticaria pigmentosa), systemic selero—
derma and psoriasis vulgaris.
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vulgaris show a considerable variation mak-
ing interpretation difficult. Both the patients
and the controls of this study had normal
renal function.
The present study suggests a correlation be-
tween changes in mucopolysaccharidc metab-
olism and serum lysozymc activity.
SUMMARY
Serum and urinary lysozymc activities were
measured in normal subjects and in patients
with mastocytosis (urticaria pigmcntosa),
systemic sclcrodcrma and psoriasis vulgaris.
in serum, a significant decrease was observed
in urticaria pigmentosa, a moderate decrease
in systemic sclcroderma, while no significant
changes were seen in psoriasis vulgaris. The
determination of urinary lysozyme demon-
strated no reliable changes.
The study suggests a correlation between
changes in mucopolysaccharidc metabolism
and serum lysozyme activity.
REFERENCES
1. Fleming, A.: On a remarkable bacteriolytic ele-
ment found in tissues and secretions. Proc.
Roy. Soc. (London) Ser. B, 93: 306, 1922.
2. Meyer, K., Palmer, J. W., Thompson, R. and
Khorazo, D.: On the mechanism of lysozyme
action. J. Biol. Chem., 113: 479, 1936.
3. Thompson, H.: Lysozyme and its relation to
the antibacterial properties of various tissues
and secretions. Arch. Path., 30: 1096, 1940.
4. Suu, V-T., Congdon, C. C. and Kretchmar,
A. L.: Increase in lysozyme activity in
kidneys of irradiation chimeras. Proc. Soc.
Exper. Biol. & Med., 113: 481, 1963.
5. Stevens, C. 0., Henderson, L. E. and Tolbert,
B. M.: Radiation chemistry of proteins, II.
Enzymatic activity and deuterium exchange
properties of lysozyme and a-chymotrypsin.
Arch. Biochem. Biophys., 107: 367, 1964.
6. Osawa, T.: Lysozyme substrates, synthesis of
p-nitrophenyl 2_acetamid-4-0-(2-acetamid-2-
deoxy-fl-D-glucopyranosyl)-2-deoxy-D-gluco-pyranoside, and its p-D-(1 — 6) isomer.
Carbohydrate Res., 1: 435, 1966.
7. Taniguchi, T. and Sasaki, S.: Reported at the
65th General Meeting of Jap. Dermat. Soc.,
•Kyoto, 1966, Skin Res. (Osaka), In press.S. Litwack, C.: Photometric determination of
lysozyme activity. Proc. Soc. Exper. Biol. &
Med., 89: 401, 1955.
9. Fogelson, S. J., Ross, A. and Lobstein, 0. R.:
A method for quantitative determination of
lysozyme activity in blood. Am. J. Dig. Dis.,
21: 327, 1954.
10. Lobstein, 0. H. and Fogelson, S. J.: The effect
of chloride concentration in the determina-
tion of lysozyme activity. Am. J. Dig. Dis.,
18: 298, 1951.
11. Jolles, P.: In The Enzymes, vol. 4, p. 341. Ed.
Boyer, P. D., Lardy, H. and Myrbkck, K.
New York, N.Y. Academic Press, 1960.
12. Salton, M. R. J. and Ghuysen, J. M.: The
structure of di- and tetra-saccharides re-
leased from cell walls by lysozyme and
strep tomyces F, enzyme and the fi(1 — 4) N-
acetylhexosaminidase activity of these en-
zymes. Biochim. Biophys. Acta, 36: 552,
1959.
13. Asboe-Hansen, C.: Dermatologic aspects of
mast cell activity. Dermatologica, 128: 51,
1964.
14. Prockop, D. J. and Davidson, W. D.: A study
of urinary and serum lysozyme in patients
with renal disease. New Engl. J. Med., 270:
269, 1964.
15. Asboe-Hansen, C.: Bullous diffuse mastocytosis
with urinary hyaluronate excretion. Treat-
ment with cyproheptadine. Acta dermat.-
venereol., 42: 211, 1962.
16. Asboe-Hansen, C. and Clausen, J.: Urinary
excretion of acid mucopolysaccharides in
twelve cases of mastocytosis (urticaria pig-
mentosa). J. Invest. Derm., 43: 81, 1964.
17. Clausen, J. and Asboe-Hansen, C.: Urinary
acid mucopolysaccharides in mastocytosis. A
new technique for quantitative estimation.
Chn. Chim. Acta, 13: 475, 1966.
18. Wilson, A. T. and Hadley, W. P.: Urinary
lysozyme. II. Lysozymuria in healthy chil-
dren and in children with miscellaneous
diseases (A sex difference). J. Pediat., 36:
45, 1950.
19. Burghartz, N. and Boosfeld, E.: Bericht dber
Lysozymuntersuchungen im Urin. Klin.
Wchnschr., 32: 182, 1954.
